Overview

Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast Cancer

Status:
Recruiting
Trial end date:
2024-01-01
Target enrollment:
0
Participant gender:
Female
Summary
This clinical trial studies the use of contrast-enhanced ultrasound (CEUS) in estimating tissue pressure in patients with breast cancer. Diagnostic procedures, such as CEUS, may help estimate tissue pressure noninvasively.
Phase:
Early Phase 1
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Thomas Jefferson University
Criteria
Inclusion Criteria:

- Provide signed and dated informed consent form

- Be conscious, willing and able to comply with all study procedures and be available
for the duration of the study

- At least 21 years old

- Be scheduled for a breast biopsy (Breast Imaging Reporting and Data System [BIRAD] 4,
4A, 4B, 4C or 5)

- Patient with an at least 1 cm mass located at < 3 cm depth, approachable by 2.5 inch
needle

- Be medically stable as determined by the investigator

- If a female of child-bearing potential, must have a negative urine pregnancy test
within 24 hours prior to administration of Definity

Exclusion Criteria:

- Females who are pregnant or nursing

- Patients who are medically unstable, patients who are seriously or terminally ill, and
patients whose clinical course is unpredictable. For example:

- Patients on life support or in a critical care unit

- Patients with unstable occlusive disease (e.g., crescendo angina)

- Patients with clinically unstable cardiac arrhythmias, such as recurrent ventricular
tachycardia

- Patients with uncontrolled congestive heart failure (New York Heart Association [NYHA]
class IV)

- Patients with recent cerebral hemorrhage

- Patients who have undergone surgery within 24 hours prior to the study sonographic
examination

- Patients with known hypersensitivity or allergy to any component of Definity

- Patients with unstable cardiopulmonary conditions or respiratory distress syndrome

- Patients with uncontrollable emphysema, pulmonary vasculitis, pulmonary hypertension
or a history of pulmonary emboli